cytarabine has been researched along with Gliosarcoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, Y; Fine, HA; Kufe, DW; Manome, Y; Mitchell, BS; Tanaka, T; Wen, PY | 1 |
| Bahar, R; Hamada, H; Kawamura, K; Maeda, T; Miyauchi, M; Namba, H; Sakiyama, S; Tagawa, M | 1 |
2 other study(ies) available for cytarabine and Gliosarcoma
| Article | Year |
|---|---|
Viral vector transduction of the human deoxycytidine kinase cDNA sensitizes glioma cells to the cytotoxic effects of cytosine arabinoside in vitro and in vivo.
Topics: Adenoviridae; Animals; Antimetabolites, Antineoplastic; Brain Neoplasms; Cytarabine; Deoxycytidine Kinase; Dose-Response Relationship, Drug; Genetic Vectors; Gliosarcoma; Humans; Male; Prodrugs; Rats; Rats, Inbred F344; Sarcoma, Experimental; Survival Analysis; Transfection | 1996 |
Transduction of the human deoxycytidine kinase gene in rodent tumor cells induces in vivo growth retardation in syngeneic hosts.
Topics: Animals; Antimetabolites, Antineoplastic; Cell Division; Colonic Neoplasms; Cytarabine; Deoxycytidine Kinase; Female; Gliosarcoma; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Rats; T-Lymphocytes; Transduction, Genetic; Tumor Cells, Cultured | 2000 |